<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="nihpa" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC4838546/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>Non-alcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838546/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association" /><meta name="citation_title" content="Non-alcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery" /><meta name="citation_authors" content="Nicolas Goossens, Yujin Hoshida, Won Min Song, Minoa Jung, Philippe Morel, Shigeki Nakagawa, Bin Zhang, Jean-Louis Frossard, Laurent Spahr, Scott L Friedman, Francesco Negro, Laura Rubbia-Brandt, Emiliano Giostra" /><meta name="citation_date" content="November 2016" /><meta name="citation_issue" content="11" /><meta name="citation_volume" content="14" /><meta name="citation_firstpage" content="1619" /><meta name="citation_doi" content="10.1016/j.cgh.2015.10.010" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4838546/?report=abstract" /><meta name="citation_pmid" content="26492845" /><meta name="DC.Title" content="Non-alcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Nicolas Goossens" /><meta name="DC.Contributor" content="Yujin Hoshida" /><meta name="DC.Contributor" content="Won Min Song" /><meta name="DC.Contributor" content="Minoa Jung" /><meta name="DC.Contributor" content="Philippe Morel" /><meta name="DC.Contributor" content="Shigeki Nakagawa" /><meta name="DC.Contributor" content="Bin Zhang" /><meta name="DC.Contributor" content="Jean-Louis Frossard" /><meta name="DC.Contributor" content="Laurent Spahr" /><meta name="DC.Contributor" content="Scott L Friedman" /><meta name="DC.Contributor" content="Francesco Negro" /><meta name="DC.Contributor" content="Laura Rubbia-Brandt" /><meta name="DC.Contributor" content="Emiliano Giostra" /><meta name="DC.Date" content="2016 Nov" /><meta name="DC.Identifier" content="10.1016/j.cgh.2015.10.010" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Non-alcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery" /><meta property="og:type" content="article" /><meta property="og:description" content="Bariatric surgery is associated with improved outcomes in subjects with severe obesity. We investigated the prognostic relevance of non-alcoholic steatohepatitis (NASH) and liver gene expression patterns in patients undergoing bariatric surgery.We performed ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838546/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4838546/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4838546/pdf/nihms731824.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="F4FC664DB4D23EE100000000006B0059.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC4838546</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" /><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><span id="pmcmata">Clin Gastroenterol Hepatol</span>. Author manuscript; available in PMC 2017 Nov 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=26492845" target="pmc_ext" ref="reftype=publisher&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal"><span class="cit">Clin Gastroenterol Hepatol. 2016 Nov; 14(11): 1619–1628. </span></a></div><span class="fm-vol-iss-date">Published online 2015 Oct 20. </span> <span class="doi">doi:  <a href="//dx.doi.org/10.1016%2Fj.cgh.2015.10.010" target="pmc_ext" ref="reftype=other&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1016/j.cgh.2015.10.010</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4838546</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS731824</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/26492845">26492845</a></div></div></div></div></div><h1 class="content-title">Non-alcoholic Steatohepatitis is Associated with Increased Mortality in Obese Patients Undergoing Bariatric Surgery</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Goossens%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598648737968" co-class="co-affbox">Nicolas Goossens</a>,<sup>(1)</sup><sup>(2)</sup> <a href="/pubmed/?term=Hoshida%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598648894352" co-class="co-affbox">Yujin Hoshida</a>,<sup>(2)</sup> <a href="/pubmed/?term=Song%20WM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598651988496" co-class="co-affbox">Won Min Song</a>,<sup>(3)</sup> <a href="/pubmed/?term=Jung%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598651444800" co-class="co-affbox">Minoa Jung</a>,<sup>(4)</sup> <a href="/pubmed/?term=Morel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598684219760" co-class="co-affbox">Philippe Morel</a>,<sup>(4)</sup> <a href="/pubmed/?term=Nakagawa%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598644134000" co-class="co-affbox">Shigeki Nakagawa</a>,<sup>(2)</sup> <a href="/pubmed/?term=Zhang%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598647609152" co-class="co-affbox">Bin Zhang</a>,<sup>(3)</sup> <a href="/pubmed/?term=Frossard%20JL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598647607168" co-class="co-affbox">Jean-Louis Frossard</a>,<sup>(1)</sup> <a href="/pubmed/?term=Spahr%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598645641040" co-class="co-affbox">Laurent Spahr</a>,<sup>(1)</sup> <a href="/pubmed/?term=Friedman%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598650449280" co-class="co-affbox">Scott L Friedman</a>,<sup>(2)</sup> <a href="/pubmed/?term=Negro%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598651574336" co-class="co-affbox">Francesco Negro</a>,<sup>(1)</sup><sup>(5)</sup> <a href="/pubmed/?term=Rubbia-Brandt%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598686733664" co-class="co-affbox">Laura Rubbia-Brandt</a>,<sup>(5)</sup> and  <a href="/pubmed/?term=Giostra%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845" class="affpopup" co-rid="_co_idm140598644475360" co-class="co-affbox">Emiliano Giostra</a><sup>(1)</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140598648737968"><h3 class="no_margin">Nicolas Goossens</h3><p><sup>(1)</sup>Division of Gastroenterology and Hepatology, University Hospital, 1205 Geneva, Switzerland</p><p><sup>(2)</sup>Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</p><div>Find articles by <a href="/pubmed/?term=Goossens%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Nicolas Goossens</a></div></div><div id="_co_idm140598648894352"><h3 class="no_margin">Yujin Hoshida</h3><p><sup>(2)</sup>Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</p><div>Find articles by <a href="/pubmed/?term=Hoshida%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Yujin Hoshida</a></div></div><div id="_co_idm140598651988496"><h3 class="no_margin">Won Min Song</h3><p><sup>(3)</sup>Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</p><div>Find articles by <a href="/pubmed/?term=Song%20WM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Won Min Song</a></div></div><div id="_co_idm140598651444800"><h3 class="no_margin">Minoa Jung</h3><p><sup>(4)</sup>Division of Surgery, University Hospital, 1205 Geneva, Switzerland</p><div>Find articles by <a href="/pubmed/?term=Jung%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Minoa Jung</a></div></div><div id="_co_idm140598684219760"><h3 class="no_margin">Philippe Morel</h3><p><sup>(4)</sup>Division of Surgery, University Hospital, 1205 Geneva, Switzerland</p><div>Find articles by <a href="/pubmed/?term=Morel%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Philippe Morel</a></div></div><div id="_co_idm140598644134000"><h3 class="no_margin">Shigeki Nakagawa</h3><p><sup>(2)</sup>Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</p><div>Find articles by <a href="/pubmed/?term=Nakagawa%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Shigeki Nakagawa</a></div></div><div id="_co_idm140598647609152"><h3 class="no_margin">Bin Zhang</h3><p><sup>(3)</sup>Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</p><div>Find articles by <a href="/pubmed/?term=Zhang%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Bin Zhang</a></div></div><div id="_co_idm140598647607168"><h3 class="no_margin">Jean-Louis Frossard</h3><p><sup>(1)</sup>Division of Gastroenterology and Hepatology, University Hospital, 1205 Geneva, Switzerland</p><div>Find articles by <a href="/pubmed/?term=Frossard%20JL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Jean-Louis Frossard</a></div></div><div id="_co_idm140598645641040"><h3 class="no_margin">Laurent Spahr</h3><p><sup>(1)</sup>Division of Gastroenterology and Hepatology, University Hospital, 1205 Geneva, Switzerland</p><div>Find articles by <a href="/pubmed/?term=Spahr%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Laurent Spahr</a></div></div><div id="_co_idm140598650449280"><h3 class="no_margin">Scott L Friedman</h3><p><sup>(2)</sup>Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</p><div>Find articles by <a href="/pubmed/?term=Friedman%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Scott L Friedman</a></div></div><div id="_co_idm140598651574336"><h3 class="no_margin">Francesco Negro</h3><p><sup>(1)</sup>Division of Gastroenterology and Hepatology, University Hospital, 1205 Geneva, Switzerland</p><p><sup>(5)</sup>Division of Pathology, University Hospital, 1205 Geneva, Switzerland</p><div>Find articles by <a href="/pubmed/?term=Negro%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Francesco Negro</a></div></div><div id="_co_idm140598686733664"><h3 class="no_margin">Laura Rubbia-Brandt</h3><p><sup>(5)</sup>Division of Pathology, University Hospital, 1205 Geneva, Switzerland</p><div>Find articles by <a href="/pubmed/?term=Rubbia-Brandt%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Laura Rubbia-Brandt</a></div></div><div id="_co_idm140598644475360"><h3 class="no_margin">Emiliano Giostra</h3><p><sup>(1)</sup>Division of Gastroenterology and Hepatology, University Hospital, 1205 Geneva, Switzerland</p><div>Find articles by <a href="/pubmed/?term=Giostra%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26492845">Emiliano Giostra</a></div></div></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140598685736576_ai" style="display:none"><div class="fm-affl" lang="en" id="A1"><sup>(1)</sup>Division of Gastroenterology and Hepatology, University Hospital, 1205 Geneva, Switzerland</div><div class="fm-affl" lang="en" id="A2"><sup>(2)</sup>Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</div><div class="fm-affl" lang="en" id="A3"><sup>(3)</sup>Department of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA</div><div class="fm-affl" lang="en" id="A4"><sup>(4)</sup>Division of Surgery, University Hospital, 1205 Geneva, Switzerland</div><div class="fm-affl" lang="en" id="A5"><sup>(5)</sup>Division of Pathology, University Hospital, 1205 Geneva, Switzerland</div><div id="FN1">Correspondence: Nicolas Goossens, MD, MSc, Division of Gastroenterology and Hepatology, Department of Medical Specialties, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland, Tel: +41 (0)22-372-93-55, Fax: +41 (0)22-372-93-66, <a href="mailto:dev@null" data-email="hc.eguch@snessoog.salocin" class="oemail">hc.eguch@snessoog.salocin</a>, Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, Box 1123, New York, NY 10029, USA and Yujin Hoshida, MD, PhD, Division of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, Box 1123, New York, NY 10029, Tel: 1-212-824-8862, Fax: 1-646-537-9576, <a href="mailto:dev@null" data-email="ude.mssm@adihsoh.nijuy" class="oemail">ude.mssm@adihsoh.nijuy</a></div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm140598685736576_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140598685736576_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm140598685736576_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div><div><a href="#FN5">Publisher's Disclaimer</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=26492845" target="pmc_ext" ref="reftype=publisher&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal">Clin Gastroenterol Hepatol</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC4838546/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="idm140598648216912" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140598648216912title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h2>Background &#x00026; Aims</h2><p id="P2" class="p p-first-last">Bariatric surgery is associated with improved outcomes in subjects with severe obesity. We investigated the prognostic relevance of non-alcoholic steatohepatitis (NASH) and liver gene expression patterns in patients undergoing bariatric surgery.</p></div><div id="S2" class="sec"><h2>Methods</h2><p id="P3" class="p p-first-last">We performed a retrospective analysis of 492 subjects who underwent gastric bypass bariatric surgery at a single center in Switzerland from January 1997 through December 2004; routine peri-operative liver biopsies were collected, analyzed histologically, and RNA was isolated. We collected data on overall survival and clinical and biochemical parameters and compared these with data from propensity score-matched subjects participating in the third National Health and Nutrition Examination Survey (NHANES III). We used liver biopsies to identify bariatric surgery patients with NASH; NHANES III participants with NASH were identified based on a hyperechogenic liver at ultrasound and increased alanine transaminase levels. We analyzed a 32-gene signature associated with NAFLD severity in the liver tissues collected from 47 bariatric surgery patients with NASH, and assessed its prognostic features using nearest template prediction and survival analysis.</p></div><div id="S3" class="sec"><h2>Results</h2><p id="P4" class="p p-first-last">At baseline, the median body mass index of patients who underwent bariatric surgery was 43.6 kg/m<sup>2</sup>; based on histologic findings, 12% had NASH and 16% had fibrosis. During a median follow-up of 10.2 years after the surgery, 4.2% of the subjects died. In multivariable Cox regression, the presence of NASH (hazard ratio [HR], 2.9; <em>P</em>=.02) and arterial hypertension (HR, 3.9; <em>P</em>=.02) were associated with overall mortality. When bariatric surgery patients were matched with NHANES III participants, bariatric surgery reduced the risk of death during the follow-up period (HR, 0.54; <em>P</em>=.04). However, bariatric surgery patients with NASH did not have a reduced risk of death compared to NHANES III participants with NASH (HR, 0.90; <em>P</em>=.85). We identified an expression pattern of 32 genes in liver tissues from patients with NASH that was associated with increased risk of death in multivariable analysis (HR, 7.7; <em>P</em>=.045).</p></div><div id="S4" class="sec sec-last"><h2>Conclusions</h2><p id="P5" class="p p-first-last">Histologically proven NASH is associated with increased risk of death within a median follow-up of 10.2 years after bariatric surgery, compared to patients who undergo bariatric surgery without NASH. The survival benefit of bariatric surgery in subjects with NASH may be reduced. A 32-gene expression pattern identified NASH patients who underwent bariatric surgery and had shorter survival times.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">post-operative complication, fatty liver disease, treatment, biomarker, NHANES III</span></div></div><div id="S5" class="tsec sec"><h2 class="head no_bottom_margin" id="S5title">Introduction</h2><p id="P6" class="p p-first">Obesity, defined as a body mass index (BMI) of over 30kg/m<sup>2</sup>, is a major public health issue affecting 34.9% of adults in the US and costing the US economy an estimated $148 billion in 2008, or almost 10% of total US healthcare spending<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056023">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056019">2</a></sup>. Globally, the prevalence of overweight (BMI greater than 25kg/m<sup>2</sup>) increased from 857 million to 2.1 billion, (29% to 37% of the world population) between 1980 and 2013 <sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977417">3</a></sup>. Obesity is strongly associated with non-alcoholic fatty liver disease (NAFLD), a clinicopathological spectrum ranging from hepatic steatosis, to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is emerging as the most common liver disease in the Western world, with up to one third of adults affected in the US <sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056040">4</a>, <a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056016">5</a></sup>. The prevalence of NAFLD in the setting of morbid obesity and bariatric surgery, ranges from 63&#x02013;99% for steatosis &#x0003e;5%, 10&#x02013;58% for NASH and 7&#x02013;74% for fibrosis depending on definition, diagnostic criteria and the distribution of risk factors in the specific population studied <sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056025">6</a></sup></p><p id="P7">Bariatric surgery is now widely performed for severely obese subjects, and has been associated with weight reduction and an improvement in obesity-related conditions including type 2 diabetes, arterial hypertension and dyslipidaemia <sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056033">7</a></sup>. Despite increasing data from case-control or cohort studies suggesting that bariatric surgery is associated with improved long-term survival, the mortality benefit depends on the risk-profile of the population with one study in Veterans Affairs medical centres reporting no benefit <sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056039">8</a>&#x02013;<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056017">10</a></sup>. Most prognostic studies in bariatric surgery-treated patients have focused on short-term postoperative outcomes <sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056037">11</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056029">12</a></sup>. Baseline factors associated with long-term mortality post bariatric surgery have not been fully established, although age, male sex, BMI over 50kg/m<sup>2</sup>, presence of comorbid conditions (including diabetes, cardiovascular disease) and active smoking have been proposed <sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056035">9</a>, <a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056028">13</a>, <a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056018">14</a></sup>. In particular, despite the high prevalence of NAFLD/NASH in this population, its relevance in long-term outcome after bariatric surgery is unknown.</p><p id="P8" class="p p-last">We aimed to study the prognostic relevance of histological and molecular parameters derived from liver biopsy specimens, on overall long-term survival in a well-characterized single-centre cohort of obese patients undergoing bariatric surgery.</p></div><div id="S6" class="tsec sec"><h2 class="head no_bottom_margin" id="S6title">Materials and Methods</h2><div id="S7" class="sec sec-first"><h3>Patient cohort (Geneva bariatric surgery cohort)</h3><p id="P9" class="p p-first-last">Five hundred severely obese patients consecutively underwent bariatric surgery (Roux-en-Y gastric bypass surgery) at Geneva University Hospital, a tertiary hospital serving the area around Geneva, Switzerland, between June 1997 and December 2004 (Geneva bariatric surgery cohort)<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056042">15</a></sup>. During surgery, patients underwent systematic cholecystectomy and left-lobe (segment 3) wedge-resection or needle liver biopsy. Patients were excluded from the study if they had chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection at baseline, no available baseline liver biopsy tissue, or previous weight-losing surgery (<a href="/pmc/articles/PMC4838546/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). Patients with significant substance abuse, including alcohol abuse (defined as more than 14 units of alcohol per week), were excluded from surgery (see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a> for additional details). This study was approved by the Institutional Review Board of Geneva University Hospital (protocol number 14&#x02013;125), and the requirement for informed consent from the patients was waived due to the retrospective nature of this study.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4838546/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598683845744" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4838546_nihms731824f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms731824f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4838546/bin/nihms731824f1.jpg" /></a></div><div id="largeobj_idm140598683845744" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4838546/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4838546/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p32">Flowchart of patient inclusion in the Geneva cohort (left) and matching with the NHANES III cohort (right). A subset of 47 patients with histologically documented NASH was assessed for a liver-based gene signature.</p></div></div></div></div><div id="S8" class="sec"><h3>Outcome assessment</h3><p id="P10" class="p p-first-last">The main outcome of interest was overall survival. Mortality data was obtained prospectively or, if the patient was lost to follow-up, it was assessed from the cantonal registry of Geneva. Cause of death was extracted from electronic medical records at our institution. Percentage excess BMI loss (EBMIL) was defined as ([preoperative BMI &#x02013; postoperative BMI] &#x000d7; 100) / (preoperative BMI &#x02013; 25). All endpoints, assessed variables and analyses were pre-planned (see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a> for additional details).</p></div><div id="S9" class="sec"><h3>Histological assessment of liver biopsy</h3><p id="P11" class="p p-first-last">All histological liver biopsy specimens were reviewed by an experienced liver histopathologist (LRB) blinded to clinical data. A threshold of 5% of hepatocytes with macrovesicular steatosis was required for the diagnosis of NAFLD. NASH was defined as an overall pattern of histological injury based on the presence of &#x0003e;5% macrovesicular steatosis, inflammation, and hepatocyte ballooning and not a NAFLD activity score (NAS) cut-off because previous reports underscore a suboptimal correlation between histological assessment of NASH and the semiquantitative NAS<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056020">16</a>, <a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056041">17</a></sup>. NAS was determined based on steatosis grade, lobular inflammation, and hepatocellular ballooning <sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056027">16</a></sup> and the fibrosis score was assessed according to the NASH clinical research network (CRN) modified Brunt methodology <sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056021">16</a></sup>.</p></div><div id="S10" class="sec"><h3>Comparison with the NHANES III cohort</h3><p id="P12" class="p p-first-last">To assess whether overall survival in the Geneva cohort differed to a control obese population, we performed propensity-score matching of the Geneva cohort subjects to subjects from the third US National Health and Nutrition Examination Survey (NHANES III) <sup><a href="#R18" rid="R18" class=" bibr popnode">18</a></sup> and compared survival of the subjects. A subset of the NHANES III cohort, who likely had NASH based on elevated ALT (&#x0003e;330 IU/L in men and &#x0003e;19 IU/L in women) and at least moderate hepatic steatosis by ultrasound (834 subjects: NHANES III NASH cohort), was propensity-score matched to the NASH subjects in the Geneva bariatric surgery cohort (see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a> for additional details).</p></div><div id="S11" class="sec"><h3>Tissue processing, RNA extraction and gene expression profiling</h3><p id="P13" class="p p-first-last">All NASH subjects with sufficient remaining formalin-fixed, paraffin-embedded (FFPE) hepatic tissue for RNA extraction (n=47) were included for gene expression profiling. Briefly, total RNA was extracted from five 5-&#x003bc;m-thick FFPE tissue sections using the High Pure RNA paraffin kit (Roche). Gene expression profiling was performed using 100&#x02013;400ng total RNA by using nCounter Digital Analyzer system (NanoString) according to the manufacturer&#x02019;s instructions. Raw transcript count data were log transformed and scaled by geometric mean of control probe data by using NanoString normalizer module implemented in GenePattern genomic analysis toolkit (<a href="http://www.broadinstitute.org/cancer/software/genepattern" ref="reftype=extlink&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">www.broadinstitute.org/cancer/software/genepattern</a>). Gene expression dataset is available at National Center for Biotechnology Information Gene Expression Omnibus database (accession number: GSE 69248).</p></div><div id="S12" class="sec sec-last"><h3>Statistical and bioinformatics analysis</h3><p id="P14" class="p p-first">Continuous and categorical variables were tested using Wilcoxon rank-sum test and Fisher&#x02019;s exact test, respectively. Association of the baseline variables with clinical outcomes were evaluated using uni- and multivariable Cox regression modelling. Propensity score-matching was performed non-parametrically using nearest-neighbour 1 to 1 matching, based on the following variables: BMI, sex, age, presence of diabetes, arterial hypertension, level of bilirubin, aspartate aminotransferase (AST), &#x003b3;-glutamyltransferase (GGT) and total cholesterol (see <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a> for additional details).</p><p id="P15" class="p p-last">A prognostic 32-gene signature reported in our previous study <sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977419">19</a></sup> was used to perform prognostic prediction by using nearest template prediction algorithm <sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056036">20</a></sup> implemented in GenePattern. Gene regulatory network was identified by using Multiscale Embedded Gene Co-expression Network Analysis (MEGENA) <sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977418">21</a>, <a href="#R22" rid="R22" class=" bibr popnode">22</a></sup>. All statistical and bioinformatics analyses were performed using GenePattern and the R statistical package version 3.1 (<a href="http://www.r-project.org" ref="reftype=extlink&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">www.r-project.org</a>).</p></div></div><div id="S13" class="tsec sec"><h2 class="head no_bottom_margin" id="S13title">Results</h2><div id="S14" class="sec sec-first"><h3>Patient characteristics of the Geneva cohort</h3><p id="P16" class="p p-first">Eight of the 500 consecutively enrolled subjects were excluded due to absence of liver biopsy or prior bariatric surgery (<a href="/pmc/articles/PMC4838546/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). Median baseline weight and BMI of the 492 patients included were 118kg and 43.6kg/m<sup>2</sup> respectively, <a href="/pmc/articles/PMC4838546/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> summarizes other baseline characteristics. At baseline histology (84% wedge-resection biopsy), 89% had steatosis in more than 5% of hepatocytes, 12% had NASH and 4% had fibrosis stage 2 or greater (<a href="/pmc/articles/PMC4838546/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). Compared to non-NASH patients, patients with NASH were more likely to be male, diabetic, hypertensive, previous or current smokers and to be older, whereas subjects with fibrosis were more likely to be male and diabetic (<a href="/pmc/articles/PMC4838546/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p36">Baseline characteristics of patients of the Geneva cohort and comparison of NASH versus non-NASH and fibrotic versus non-fibrotic subjects.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598649533120" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th valign="bottom" rowspan="2" align="left" colspan="1">Variable</th><th valign="bottom" align="center" rowspan="1" colspan="1">All subjects
<hr /></th><th colspan="2" valign="bottom" align="center" rowspan="1">NASH comparison
<hr /></th><th colspan="2" valign="bottom" align="center" rowspan="1">Fibrosis comparison
<hr /></th><th colspan="2" valign="bottom" align="center" rowspan="1">Statistical comparison
<hr /></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1"></th><th valign="bottom" align="center" rowspan="1" colspan="1">NASH</th><th valign="bottom" align="center" rowspan="1" colspan="1">non-NASH</th><th valign="bottom" align="center" rowspan="1" colspan="1">Fibrosis</th><th valign="bottom" align="center" rowspan="1" colspan="1">Non-fibrosis</th><th valign="bottom" align="center" rowspan="1" colspan="1">NASH vs non-NASH, p-value</th><th valign="bottom" align="center" rowspan="1" colspan="1">Fibrosis vs non-fibrosis, p-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">N</td><td align="center" valign="top" rowspan="1" colspan="1">492</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">433</td><td align="center" valign="top" rowspan="1" colspan="1">77</td><td align="center" valign="top" rowspan="1" colspan="1">415</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td colspan="8" align="left" valign="top" rowspan="1"><strong>Clinical</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male sex, n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">89 (18)</td><td align="center" valign="top" rowspan="1" colspan="1">22 (13)</td><td align="center" valign="top" rowspan="1" colspan="1">67 (16)</td><td align="center" valign="top" rowspan="1" colspan="1">26 (34)</td><td align="center" valign="top" rowspan="1" colspan="1">63 (15)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.004</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.007</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (y)</td><td align="center" valign="top" rowspan="1" colspan="1">41 (34&#x02013;49)</td><td align="center" valign="top" rowspan="1" colspan="1">46 (40&#x02013;53)</td><td align="center" valign="top" rowspan="1" colspan="1">40 (33&#x02013;48)</td><td align="center" valign="top" rowspan="1" colspan="1">43.6 (36&#x02013;50)</td><td align="center" valign="top" rowspan="1" colspan="1">40.3 (33&#x02013;49)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.004</strong></td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (&#x0003e;50y), n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">104 (21)</td><td align="center" valign="top" rowspan="1" colspan="1">20 (34)</td><td align="center" valign="top" rowspan="1" colspan="1">84 (19)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (25)</td><td align="center" valign="top" rowspan="1" colspan="1">85 (21)</td><td align="center" valign="top" rowspan="1" colspan="1">0.4</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">118 (108&#x02013;132)</td><td align="center" valign="top" rowspan="1" colspan="1">123 (161&#x02013;174)</td><td align="center" valign="top" rowspan="1" colspan="1">117 (110&#x02013;130)</td><td align="center" valign="top" rowspan="1" colspan="1">125 (112&#x02013;140)</td><td align="center" valign="top" rowspan="1" colspan="1">117 (108&#x02013;131)</td><td align="center" valign="top" rowspan="1" colspan="1">0.4</td><td align="center" valign="top" rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">43.6 (41&#x02013;47)</td><td align="center" valign="top" rowspan="1" colspan="1">44 (42&#x02013;49)</td><td align="center" valign="top" rowspan="1" colspan="1">43 (41&#x02013;47)</td><td align="center" valign="top" rowspan="1" colspan="1">44.4 (42&#x02013;48)</td><td align="center" valign="top" rowspan="1" colspan="1">43.2 (41&#x02013;47)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (&#x0003e;45kg/m<sup>2</sup>), n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">181 (37)</td><td align="center" valign="top" rowspan="1" colspan="1">25 (42)</td><td align="center" valign="top" rowspan="1" colspan="1">156 (36)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (39)</td><td align="center" valign="top" rowspan="1" colspan="1">151 (36)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes, n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">82 (17)</td><td align="center" valign="top" rowspan="1" colspan="1">27 (46)</td><td align="center" valign="top" rowspan="1" colspan="1">55 (13)</td><td align="center" valign="top" rowspan="1" colspan="1">27 (35)</td><td align="center" valign="top" rowspan="1" colspan="1">55 (13)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Arterial Hypertension, n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">155 (32)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (51)</td><td align="center" valign="top" rowspan="1" colspan="1">125 (29)</td><td align="center" valign="top" rowspan="1" colspan="1">31 (40)</td><td align="center" valign="top" rowspan="1" colspan="1">124 (30)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.03</strong></td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OSA, n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">67 (13)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (20)</td><td align="center" valign="top" rowspan="1" colspan="1">55 (13)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (16)</td><td align="center" valign="top" rowspan="1" colspan="1">55 (13)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ever smoked (n=297), n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">136 (46)</td><td align="center" valign="top" rowspan="1" colspan="1">35 (66)</td><td align="center" valign="top" rowspan="1" colspan="1">101 (41)</td><td align="center" valign="top" rowspan="1" colspan="1">43 (62)</td><td align="center" valign="top" rowspan="1" colspan="1">93 (41)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.03</strong></td><td align="center" valign="top" rowspan="1" colspan="1">0.051</td></tr><tr><td colspan="8" align="left" valign="top" rowspan="1"><strong>Biological</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Platelets (&#x000d7;10<sup>9</sup>/L)</td><td align="center" valign="top" rowspan="1" colspan="1">268 (226&#x02013;310)</td><td align="center" valign="top" rowspan="1" colspan="1">255 (200&#x02013;300)</td><td align="center" valign="top" rowspan="1" colspan="1">274 (240&#x02013;310)</td><td align="center" valign="top" rowspan="1" colspan="1">256 (220&#x02013;310)</td><td align="center" valign="top" rowspan="1" colspan="1">272 (230&#x02013;310)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Albumin (g/L)</td><td align="center" valign="top" rowspan="1" colspan="1">36 (35&#x02013;39)</td><td align="center" valign="top" rowspan="1" colspan="1">38 (35&#x02013;39)</td><td align="center" valign="top" rowspan="1" colspan="1">36 (35&#x02013;38)</td><td align="center" valign="top" rowspan="1" colspan="1">38 (35&#x02013;39)</td><td align="center" valign="top" rowspan="1" colspan="1">36 (35&#x02013;38)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ferritin (ng/mL)</td><td align="center" valign="top" rowspan="1" colspan="1">74 (35&#x02013;142)</td><td align="center" valign="top" rowspan="1" colspan="1">147 (90&#x02013;310)</td><td align="center" valign="top" rowspan="1" colspan="1">65.5 (32&#x02013;120)</td><td align="center" valign="top" rowspan="1" colspan="1">137 (55&#x02013;280)</td><td align="center" valign="top" rowspan="1" colspan="1">70 (31&#x02013;122)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bilirubin (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">0.59 (0.47&#x02013;0.76)</td><td align="center" valign="top" rowspan="1" colspan="1">0.65 (0.5&#x02013;0.8)</td><td align="center" valign="top" rowspan="1" colspan="1">0.60 (0.5&#x02013;0.8)</td><td align="center" valign="top" rowspan="1" colspan="1">0.64 (0.5&#x02013;0.8)</td><td align="center" valign="top" rowspan="1" colspan="1">0.60 (0.5&#x02013;0.8)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AST (IU/L)</td><td align="center" valign="top" rowspan="1" colspan="1">20 (16&#x02013;27)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (25&#x02013;42)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (15&#x02013;24)</td><td align="center" valign="top" rowspan="1" colspan="1">28 (21&#x02013;42)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (15&#x02013;24)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALT (IU/L)</td><td align="center" valign="top" rowspan="1" colspan="1">26 (17&#x02013;42)</td><td align="center" valign="top" rowspan="1" colspan="1">47 (34&#x02013;70)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (17&#x02013;36)</td><td align="center" valign="top" rowspan="1" colspan="1">44 (23&#x02013;78)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (17&#x02013;36)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AlkPh (IU/L)</td><td align="center" valign="top" rowspan="1" colspan="1">71 (60&#x02013;84)</td><td align="center" valign="top" rowspan="1" colspan="1">72 (60&#x02013;94)</td><td align="center" valign="top" rowspan="1" colspan="1">71 (60&#x02013;84)</td><td align="center" valign="top" rowspan="1" colspan="1">74 (62&#x02013;91)</td><td align="center" valign="top" rowspan="1" colspan="1">70 (60&#x02013;84)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GGT (IU/L)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (20&#x02013;48)</td><td align="center" valign="top" rowspan="1" colspan="1">52 (36&#x02013;92)</td><td align="center" valign="top" rowspan="1" colspan="1">27.5 (19&#x02013;43)</td><td align="center" valign="top" rowspan="1" colspan="1">48 (34&#x02013;85)</td><td align="center" valign="top" rowspan="1" colspan="1">27 (19&#x02013;43)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total cholesterol (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">200 (170&#x02013;230)</td><td align="center" valign="top" rowspan="1" colspan="1">200 (180&#x02013;240)</td><td align="center" valign="top" rowspan="1" colspan="1">200 (170&#x02013;220)</td><td align="center" valign="top" rowspan="1" colspan="1">210 (170&#x02013;250)</td><td align="center" valign="top" rowspan="1" colspan="1">200 (170&#x02013;220)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL cholesterol (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">140 (110&#x02013;170)</td><td align="center" valign="top" rowspan="1" colspan="1">150 (120&#x02013;190)</td><td align="center" valign="top" rowspan="1" colspan="1">130 (110&#x02013;160)</td><td align="center" valign="top" rowspan="1" colspan="1">150 (130&#x02013;190)</td><td align="center" valign="top" rowspan="1" colspan="1">130 (100&#x02013;170)</td><td align="center" valign="top" rowspan="1" colspan="1">1.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Triglycerides (mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">120 (90&#x02013;190)</td><td align="center" valign="top" rowspan="1" colspan="1">160 (115&#x02013;210)</td><td align="center" valign="top" rowspan="1" colspan="1">115 (80&#x02013;180)</td><td align="center" valign="top" rowspan="1" colspan="1">160 (115&#x02013;230)</td><td align="center" valign="top" rowspan="1" colspan="1">115 (80&#x02013;180)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.004</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HOMA-IR</td><td align="center" valign="top" rowspan="1" colspan="1">5.4 (3.6&#x02013;8.5)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (5.3&#x02013;17)</td><td align="center" valign="top" rowspan="1" colspan="1">5.1 (3.4&#x02013;8.2)</td><td align="center" valign="top" rowspan="1" colspan="1">8.7 (5.4&#x02013;16)</td><td align="center" valign="top" rowspan="1" colspan="1">5.1 (3.4&#x02013;7.9)</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.002</strong></td></tr></tbody></table></div><div id="largeobj_idm140598649533120" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4838546/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p37" class="p p-first-last">AlkPh, alkaline phosphatase; GGT, &#x003b3;-glutamyltransferase; HOMA-IR, homeostatic model assessment-insulin resistance; OSA, obstructive sleep apnoea.</p></div><div id="TFN2"><p id="__p38" class="p p-first-last">Continuous variables: median (IQR). P-values adjusted for multiple testing (Bonferroni correction).</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p39">Baseline histological data of the Geneva cohort.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598646681504" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Variable</th><th valign="bottom" align="center" rowspan="1" colspan="1">All subjects</th><th valign="bottom" align="center" rowspan="1" colspan="1">NASH</th><th valign="bottom" align="center" rowspan="1" colspan="1">Fibrosis</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">N</td><td align="center" valign="top" rowspan="1" colspan="1">492</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">77</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NAFLD (steatosis &#x0003e;5%), n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">439 (89)</td><td align="center" valign="top" rowspan="1" colspan="1">59 (100)</td><td align="center" valign="top" rowspan="1" colspan="1">73 (95)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NASH, n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">59 (12)</td><td align="center" valign="top" rowspan="1" colspan="1">59 (100)</td><td align="center" valign="top" rowspan="1" colspan="1">47 (61)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fibrosis, n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">77 (16)</td><td align="center" valign="top" rowspan="1" colspan="1">47 (78)</td><td align="center" valign="top" rowspan="1" colspan="1">77 (100)</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1"><strong>NAS scoring</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Overall NAS score</td><td align="center" valign="top" rowspan="1" colspan="1">2 (1&#x02013;3)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (4&#x02013;6)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (2&#x02013;5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Steatosis</td><td align="center" valign="top" rowspan="1" colspan="1">2 (1&#x02013;2)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (2.5&#x02013;3)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (2&#x02013;3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Lobular Inflammation</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0&#x02013;0)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1&#x02013;1)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (0&#x02013;2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ballooning</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0&#x02013;0)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1&#x02013;2)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (0&#x02013;1)</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1"><strong>Fibrosis, n (%)</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;stage 0</td><td align="center" valign="top" rowspan="1" colspan="1">415 (84)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (20)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0)</td></tr><tr><td colspan="4" align="left" valign="top" rowspan="1">&#x02003;stage 1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;stage 1A</td><td align="center" valign="top" rowspan="1" colspan="1">30 (6.1)</td><td align="center" valign="top" rowspan="1" colspan="1">21 (36)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (39)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;stage 1B</td><td align="center" valign="top" rowspan="1" colspan="1">7 (1.4)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (10)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;stage 1C</td><td align="center" valign="top" rowspan="1" colspan="1">22 (4.5)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (3)</td><td align="center" valign="top" rowspan="1" colspan="1">22 (29)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;stage 2</td><td align="center" valign="top" rowspan="1" colspan="1">8 (1.6)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (14)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (10)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;stage 3</td><td align="center" valign="top" rowspan="1" colspan="1">9 (1.8)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (12)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;stage 4</td><td align="center" valign="top" rowspan="1" colspan="1">1 (0.2)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1)</td></tr></tbody></table></div><div id="largeobj_idm140598646681504" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4838546/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><p id="__p40" class="p p-first-last">NAS, non-alcoholic fatty liver disease activity score.</p></div><div id="TFN4"><p id="__p41" class="p p-first-last">Continuous variables: median (IQR).</p></div></div></div><p id="P17" class="p p-last">Prospectively assessed weight and BMI was available in 81%, 67%, 53% and 34% 1, 2, 3 and 5 years after bariatric surgery, respectively (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>). Median weight loss and EBMIL at 1 year after bariatric surgery were 38kg and 74% respectively, similar to other reports and systematic reviews of bariatric surgery effectiveness<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056030">7</a></sup>. No patient required bariatric surgery reversal. In univariable and multivariable analysis, EBMIL greater than 50% was not associated with features at liver histology but inversely correlated to male sex and baseline BMI greater than 45kg/m<sup>2</sup> (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 2</a>).</p></div><div id="S15" class="sec"><h3>Overall Survival</h3><p id="P18" class="p p-first">Median follow-up of the Geneva cohort was 10.2 years (7.0&#x02013;12 years). Overall, 21/492 (4.3%) individuals died during follow-up, causes of death were cerebrovascular disease in 2/21, non-hepatic neoplasia in 4/21 (all more than 5 years after bariatric surgery), sepsis in 7/21 (not at time of initial surgery), other causes in 7/21 patients (including pulmonary embolus, suicide, accident and one cirrhosis initially attributed to alcohol liver disease but reassessed as multifactorial aetiology due to the short history of alcohol consumption prior to death) and 3/21 unknown. When stratified by cause of death, NASH was associated with death from sepsis in univariable analysis along with other baseline factors (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 3</a>) whereas fibrosis had borderline significance (p=0.067). Events were too rare in the other causes of death to test association with baseline factors.</p><p id="P19">Baseline factors associated with overall mortality in univariable survival were male sex, age greater than 50 years, presence of diabetes, arterial hypertension, presence of histological NASH and liver fibrosis (<a href="/pmc/articles/PMC4838546/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> and <a href="/pmc/articles/PMC4838546/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A&#x02013;B</span></a>). In Cox regression multivariable stepwise AIC model selection only NASH (hazard ratio [HR] 2.9, p=0.02) and arterial hypertension (HR 3.9, p=0.02) were independently associated with overall mortality (<a href="/pmc/articles/PMC4838546/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). Neither liver fibrosis nor the interaction term between NASH and liver fibrosis were associated with overall mortality in the multivariable Cox regression.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC4838546/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598644412176" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4838546_nihms731824f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms731824f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4838546/bin/nihms731824f2.jpg" /></a></div><div id="largeobj_idm140598644412176" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4838546/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC4838546/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p33">A&#x02013;D, Survival of the Geneva bariatric surgery cohort stratified by NASH, fibrosis, NAS score and fibrosis score. E-F, Survival comparison of propensity-score matched Geneva and NHANES III cohorts (n=335 in each cohort). F, Survival comparison of NASH subjects in the propensity-score matched Geneva and NHANES III cohorts (n=41 in each cohort).</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p42">Predictors of overall survival in the Geneva cohort.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598648165200" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th valign="middle" rowspan="2" align="left" colspan="1">Variable</th><th colspan="2" valign="bottom" align="center" rowspan="1">Number in each group
<hr /></th><th colspan="3" valign="bottom" align="center" rowspan="1">Univariable analysis
<hr /></th><th colspan="3" valign="bottom" align="center" rowspan="1">Mutivariable analysis
<hr /></th></tr><tr><th valign="bottom" align="center" rowspan="1" colspan="1">Died, n (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">Alive, n (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">HR</th><th valign="bottom" align="center" rowspan="1" colspan="1">95% CI</th><th valign="bottom" align="center" rowspan="1" colspan="1">p-value</th><th valign="bottom" align="center" rowspan="1" colspan="1">HR</th><th valign="bottom" align="center" rowspan="1" colspan="1">95% CI</th><th valign="bottom" align="center" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Total n</td><td align="center" valign="top" rowspan="1" colspan="1">21 (4)</td><td align="center" valign="top" rowspan="1" colspan="1">471 (96)</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td colspan="9" align="left" valign="top" rowspan="1"><strong>Clinical</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male sex</td><td align="center" valign="top" rowspan="1" colspan="1">9 (43)</td><td align="center" valign="top" rowspan="1" colspan="1">80 (17)</td><td align="center" valign="top" rowspan="1" colspan="1">3.8</td><td align="center" valign="top" rowspan="1" colspan="1">1.6&#x02013;9.0</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.001</strong></td><td align="center" valign="top" rowspan="1" colspan="1">2.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.8&#x02013;4.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Age (&#x0003e; 50y)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (57)</td><td align="center" valign="top" rowspan="1" colspan="1">92 (19)</td><td align="center" valign="top" rowspan="1" colspan="1">5.3</td><td align="center" valign="top" rowspan="1" colspan="1">2.2&#x02013;13</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>&#x0003c;0.001</strong></td><td align="center" valign="top" rowspan="1" colspan="1">2.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.9&#x02013;6.4</td><td align="center" valign="top" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;BMI (&#x0003e; 45kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (52)</td><td align="center" valign="top" rowspan="1" colspan="1">170 (36)</td><td align="center" valign="top" rowspan="1" colspan="1">2.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.90&#x02013;5.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Diabetes</td><td align="center" valign="top" rowspan="1" colspan="1">8 (38)</td><td align="center" valign="top" rowspan="1" colspan="1">74 (16)</td><td align="center" valign="top" rowspan="1" colspan="1">3.3</td><td align="center" valign="top" rowspan="1" colspan="1">1.4&#x02013;8.0</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.005</strong></td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Arterial hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">16 (76)</td><td align="center" valign="top" rowspan="1" colspan="1">139 (30)</td><td align="center" valign="top" rowspan="1" colspan="1">7.9</td><td align="center" valign="top" rowspan="1" colspan="1">2.9&#x02013;22</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>&#x0003c;0.001</strong></td><td align="center" valign="top" rowspan="1" colspan="1">3.9</td><td align="center" valign="top" rowspan="1" colspan="1">1.2&#x02013;12</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.02</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;OSA</td><td align="center" valign="top" rowspan="1" colspan="1">4 (19)</td><td align="center" valign="top" rowspan="1" colspan="1">63 (13)</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.53&#x02013;4.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.41</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ever smoked</td><td align="center" valign="top" rowspan="1" colspan="1">9 (45)</td><td align="center" valign="top" rowspan="1" colspan="1">127 (46)</td><td align="center" valign="top" rowspan="1" colspan="1">0.96</td><td align="center" valign="top" rowspan="1" colspan="1">0.40&#x02013;2.3</td><td align="center" valign="top" rowspan="1" colspan="1">0.92</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td colspan="9" align="left" valign="top" rowspan="1"><strong>Histology</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;NAFLD (steatosis &#x0003e;5%)</td><td align="center" valign="top" rowspan="1" colspan="1">20 (95)</td><td align="center" valign="top" rowspan="1" colspan="1">419 (89)</td><td align="center" valign="top" rowspan="1" colspan="1">2.2</td><td align="center" valign="top" rowspan="1" colspan="1">0.29&#x02013;16</td><td align="center" valign="top" rowspan="1" colspan="1">0.43</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;NASH</td><td align="center" valign="top" rowspan="1" colspan="1">8 (38)</td><td align="center" valign="top" rowspan="1" colspan="1">51 (11)</td><td align="center" valign="top" rowspan="1" colspan="1">5.1</td><td align="center" valign="top" rowspan="1" colspan="1">2.1&#x02013;12</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>&#x0003c;0.001</strong></td><td align="center" valign="top" rowspan="1" colspan="1">2.9</td><td align="center" valign="top" rowspan="1" colspan="1">1.2&#x02013;7.4</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.02</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Fibrosis</td><td align="center" valign="top" rowspan="1" colspan="1">8 (38)</td><td align="center" valign="top" rowspan="1" colspan="1">69 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">3.5</td><td align="center" valign="top" rowspan="1" colspan="1">1.5&#x02013;8.6</td><td align="center" valign="top" rowspan="1" colspan="1"><strong>0.003</strong></td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td colspan="9" align="left" valign="top" rowspan="1"><strong>Biological</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Platelets (&#x0003e; ULN)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (10)</td><td align="center" valign="top" rowspan="1" colspan="1">18 (14)</td><td align="center" valign="top" rowspan="1" colspan="1">0.79</td><td align="center" valign="top" rowspan="1" colspan="1">0.18&#x02013;3.4</td><td align="center" valign="top" rowspan="1" colspan="1">0.75</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Albumin (&#x0003c; 35 g/L)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (35)</td><td align="center" valign="top" rowspan="1" colspan="1">48 (38)</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td><td align="center" valign="top" rowspan="1" colspan="1">0.42&#x02013;2.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.89</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ferritin (&#x0003e;1.5 &#x000d7; ULN)<sup>*</sup></td><td align="center" valign="top" rowspan="1" colspan="1">1 (5)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (3)</td><td align="center" valign="top" rowspan="1" colspan="1">1.51</td><td align="center" valign="top" rowspan="1" colspan="1">0.20&#x02013;11</td><td align="center" valign="top" rowspan="1" colspan="1">0.69</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bilirubin (&#x0003e; ULN)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (5)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">2.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.37&#x02013;21</td><td align="center" valign="top" rowspan="1" colspan="1">0.3</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;AST (&#x0003e; ULN)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (10)</td><td align="center" valign="top" rowspan="1" colspan="1">21 (5)</td><td align="center" valign="top" rowspan="1" colspan="1">2.3</td><td align="center" valign="top" rowspan="1" colspan="1">0.53&#x02013;9.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.25</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;ALT (&#x0003e; ULN)<sup>+</sup></td><td align="center" valign="top" rowspan="1" colspan="1">16 (76)</td><td align="center" valign="top" rowspan="1" colspan="1">296 (64)</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td><td align="center" valign="top" rowspan="1" colspan="1">0.68&#x02013;5.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.22</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;AlkPh (&#x0003e;ULN)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (5)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (2)</td><td align="center" valign="top" rowspan="1" colspan="1">2.4</td><td align="center" valign="top" rowspan="1" colspan="1">0.32&#x02013;18</td><td align="center" valign="top" rowspan="1" colspan="1">0.37</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;GGT (&#x0003e; ULN)</td><td align="center" valign="top" rowspan="1" colspan="1">14 (70)</td><td align="center" valign="top" rowspan="1" colspan="1">212 (47)</td><td align="center" valign="top" rowspan="1" colspan="1">2.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.98&#x02013;6.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.054</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Total cholesterol (&#x0003e; 240mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (19)</td><td align="center" valign="top" rowspan="1" colspan="1">75 (17)</td><td align="center" valign="top" rowspan="1" colspan="1">1.2</td><td align="center" valign="top" rowspan="1" colspan="1">0.41&#x02013;3.6</td><td align="center" valign="top" rowspan="1" colspan="1">0.73</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Triglycerides ((&#x0003e; 200mg/dL)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (19)</td><td align="center" valign="top" rowspan="1" colspan="1">74 (17)</td><td align="center" valign="top" rowspan="1" colspan="1">1.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.36&#x02013;3.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;HOMA-IR (&#x0003e;3)</td><td align="center" valign="top" rowspan="1" colspan="1">15 (88)</td><td align="center" valign="top" rowspan="1" colspan="1">321 (81)</td><td align="center" valign="top" rowspan="1" colspan="1">2.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.46&#x02013;9.2</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr><tr><td colspan="9" align="left" valign="top" rowspan="1"><strong>Outcome</strong></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;EBMIL &#x0003e; 50%</td><td align="center" valign="top" rowspan="1" colspan="1">14 (78)</td><td align="center" valign="top" rowspan="1" colspan="1">286 (72)</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td><td align="center" valign="top" rowspan="1" colspan="1">0.62&#x02013;5.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.27</td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td><td align="center" valign="top" rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140598648165200" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4838546/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN5"><p id="__p43" class="p p-first-last">AIC, Akaike information criteria; AlkPh, alkaline phosphatase; CI, confidence interval; EBMIL, excess BMI loss; GGT, &#x003b3;-glutamyltransferase; HOMA-IR, homeostatic model assessment-insulin resistance HR, hazard ratio; OSA, obstructive sleep apnoea; ULN, upper limit of normal</p></div><div id="TFN6"><sup>*</sup>Ferritin: &#x0003e;300ng/ml in women and &#x0003e; 450 ng/ml in men,</div><div id="TFN7"><sup>+</sup>ALT: Men: ULN3&#x0003c;330 IU/L, Women: ULN3&#x0003c;319 IU/L</div></div></div><p id="P20">To further clarify whether metabolic cofactors were driving the association between increased mortality and NASH, we performed a matched case-control analysis within the Geneva cohort. We matched the 59 NASH subjects with 59 non-NASH controls for age, presence of diabetes and arterial hypertension. This yielded 59 pairs of NASH cases and matched non-NASH controls with identical proportions of diabetes (46%), arterial hypertension (51%) and age greater than 50 years (34%) although, as expected, AST, ALT and GGT were significantly elevated in the NASH group (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 4</a>). Despite matching for features of the metabolic syndrome, NASH at baseline biopsy was still associated with increased long-term mortality (HR=8.8, 95%CI 1.1&#x02013;70, p=0.04).</p><p id="P21" class="p p-last">When comparing baseline liver histology between subjects alive and dead at end of follow-up, deceased subjects had a higher proportion of NASH (38% versus 11%, p=0.01), fibrosis (38% versus 18%, p=0.045) a higher median NAS score (3 versus 2, p&#x0003c;0.001) and more advanced fibrosis (p=0.03) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 5</a>). In survival analysis, individuals with a NAS score &#x02265; 5 had significantly higher mortality than patients with a NAS score of &#x02264; 2 (p&#x0003c;0.001), whereas patients with fibrosis stage 1 and stage &#x02265; 2 had a significantly increased mortality than patients without fibrosis (p=0.048 and p=0.005 respectively) (<a href="/pmc/articles/PMC4838546/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2C&#x02013;D</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 6</a>).</p></div><div id="S16" class="sec"><h3>Comparison with matched obese subjects in NHANES III</h3><p id="P22" class="p p-first">In order to assess the effect of bariatric surgery on the survival of obese patients, the Geneva cohort was matched, using propensity-score matching, to 18723 subjects from the NHANES III cohort (<a href="/pmc/articles/PMC4838546/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>: propensity-score matching #1). This yielded 335 matched pairs of patients with similar baseline characteristics (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 7</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1A&#x02013;B</a>). Mortality was significantly reduced in the patients undergoing bariatric surgery in univariable and multivariable analysis (HR 0.54, p=0.035, <a href="/pmc/articles/PMC4838546/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2E</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 8</a>).</p><p id="P23" class="p p-last">To assess the potential impact of bariatric surgery on overall survival in patients with NASH, we matched the subset of patients in the Geneva cohort with histological NASH (n=59) with subjects from NHANES III with at least moderate steatosis on liver ultrasound and raised ALT (<a href="/pmc/articles/PMC4838546/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>: propensity-score matching #2). In the Geneva cohort, when compared to the histological gold standard, this surrogate marker of NASH had a sensitivity of 74%, specificity of 96%, positive predictive value of 83% and negative predictive value of 93% for the diagnosis of NASH. This index was confirmed to be prognostic in the Geneva cohort as the 145 subjects with steatosis and raised ALT had increased mortality (HR 3.7, p=0.003). This matching yielded 41 pairs of subjects with similar baseline characteristics despite higher ferritin in the NHANES III cohort (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 9</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 2A&#x02013;B</a>). In this analysis, bariatric surgery was not significantly associated with reduced survival (<a href="/pmc/articles/PMC4838546/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2F</span></a>), whereas older age was associated with worse survival (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 10</a>).</p></div><div id="S17" class="sec sec-last"><h3>Gene signature-based prognostication in NASH patients</h3><p id="P24" class="p p-first">We next assessed whether molecular-based risk assessment in hepatic tissue of subjects undergoing bariatric surgery could improve risk stratification, especially in NASH patients. Forty-seven NASH subjects had available FFPE tissue blocks for transcriptome analysis. Median BMI and weight were 44.6kg/m<sup>2</sup> and 125kg respectively, median NAS was 5 and seven subjects (15%) died during follow-up (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 11</a>). A previously published 32-gene signature <sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977414">19</a></sup> (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 12</a>) was found to be significantly associated with NAFLD severity in a previous cohort of 72 NAFLD subjects <sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977422">23</a></sup> (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3</a>). The 32-gene poor prognosis prediction was associated with increased overall mortality in Geneva cohort NASH subjects (log-rank p=0.03). In multivariable Cox regression modelling, age greater than 50 years (HR 14, p=0.02) and 32-gene signature poor prognosis prediction (HR 9.0, p=0.045) were independently associated with increased overall mortality (<a href="/pmc/articles/PMC4838546/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A&#x02013;B</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 13</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC4838546/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140598648279776" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4838546_nihms731824f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms731824f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4838546/bin/nihms731824f3.jpg" /></a></div><div id="largeobj_idm140598648279776" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4838546/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC4838546/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p34">Gene expression signature prediction of overall survival in 47 NASH patients in the Geneva bariatric surgery cohort. A, 32-gene signature expression pattern, red and blue colors in the heatmap indicate high and low expression respectively. Each patient is represented as a column, individual genes are represented as rows. B, Survival of subjects based on their 32-gene prediction group. C, Gene regulatory network in NASH tissues. Each gene sub-module in the network is indicated by a different color and number. Enriched molecular pathways associated to 4 specific modules are highlighted.</p><p id="__p35">EGF, epidermal growth factor; mTOR, mechanistic target of rapamycin</p></div></div></div><p id="P25" class="p p-last">In the NASH gene expression profiles, MEGENA identified 9 distinct gene regulatory modules (<a href="/pmc/articles/PMC4838546/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3C</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 14</a>). A tightly clustered gene module (no.4) was centred on a hub gene, epidermal growth factor (EGF), a fibrogenic and carcinogenic driver implicated as an HCC chemoprevention target in our previous study <sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056015">24</a></sup>, which has led to initiation of a clinical trial of EGF receptor inhibitor, erlotinib (clinicaltrials.gov, trial number <a id="__tag_565056048" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT02273362" ref="reftype=extlink-clinical-trial&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&amp;rendering-type=normal"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT02273362","term_id":"NCT02273362"}}</span>NCT02273362</a>). Module no.6 was enriched with TNF-&#x003b1; signalling via NF-&#x003ba;B pathway (p&#x0003c;0.001), indicating presence of inflammatory pathway activation in NASH-affected liver (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 15</a>). Module no.5 was enriched with collagen-encoding genes, <em>TGF-&#x003b2;</em> target genes such as <em>TGFB1I1</em>, epithelial-mesenchymal transition pathway (p=0.002), as well as 2 previously published hepatic stellate cell signatures <sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056032">25</a>, <a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977424">26</a></sup>, evidencing activated fibrogenesis (p&#x0003c;0.05).</p></div></div><div id="S18" class="tsec sec"><h2 class="head no_bottom_margin" id="S18title">Discussion</h2><p id="P26" class="p p-first">In this retrospective, single-centre cohort, we have demonstrated that presence of NASH at baseline liver histology of severely obese subjects undergoing bariatric surgery is associated with increased long-term mortality compared to those without NASH. Of greater concern, despite reduced overall mortality for obese subjects undergoing bariatric surgery compared to matched, non-surgical, subjects, patients with NASH at baseline did not have improved survival after bariatric surgery. Importantly, we identified that a poor prognosis 32-gene signature prediction <sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977416">19</a></sup> was associated with NAFLD severity in a previously published cohort of 72 subjects with NAFLD <sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977415">23</a></sup> and could identify poor prognosis NASH subjects in the Geneva cohort with increased long-term mortality compared to control obese NASH subjects.</p><p id="P27">To our knowledge, our study is the first analysis of the relationship between perioperative findings at liver biopsy and long term outcomes after bariatric surgery. Previous reports have demonstrated that the beneficial effects of bariatric surgery are not only linked to a reduction of body weight but also to an improvement in metabolic parameters such as type 2 diabetes, hypertension and dyslipidaemia <sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056024">7</a></sup>. Paired liver biopsy studies have also demonstrated a reduction of NASH prevalence over 5 years after surgery and improvement of fibrosis <sup><a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056034">27</a>, <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977420">28</a></sup>. Nevertheless, despite these encouraging results, our data suggests that subjects with baseline NASH have an increased mortality after bariatric surgery and their overall survival may not improve after bariatric surgery despite no significant difference in weight loss. Further studies will have to examine whether persistence of diabetes was associated with NASH and long-term mortality. Interestingly, when performing a subgroup analysis on cause of death in our cohort, NASH was associated with mortality from sepsis. This could suggest that the association between NASH and mortality in our study captures a risk factor for non-hepatic mortality as underlined by the finding that only one person died from liver-related cause in our cohort. This could also explain why the association with overall mortality and NASH seemed stronger than the association with fibrosis, as opposed to longitudinal studies in non-bariatric surgery NAFLD subjects, indicating again that NASH could be a better predictor of overall, non-hepatic mortality whilst fibrosis may better predict liver-related mortality <sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056022">29</a>, <a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977423">30</a></sup>. In addition, the finding that TNF-&#x003b1; signalling was enriched in one of the gene regulatory module, may suggest a link with altered intestinal permeability <sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056038">31</a></sup> and possibly a lack of reversal to a more favourable metabolic profile in a subgroup of individuals captured by the gene signature.</p><p id="P28">Potential limitations of our study include the selection of different populations for our bariatric surgery cohort and the US-based control NHANES III cohort although we performed careful propensity-score matching to minimize bias with well-matched major predictors of prognosis such as age, or features of the metabolic syndrome. Although the diagnosis of NASH could not be histologically documented in the control NHANES III cohort due to the absence of liver biopsy, we believe that our two-tier selection of patients, first by selecting subjects with steatosis and raised ALT then by propensity-matching these subjects to the histologically documented Geneva cohort NASH subjects, limited potential biases. In addition, we tested the diagnostic performance of this previously reported <sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584977421">32</a>, <a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056031">33</a></sup> non-invasive definition of NASH in the Geneva cohort and confirmed that it was associated with prognosis. Finally, although potential bariatric surgery in the NHANES III control group could represent a bias, only 2.9% of adults eligible for bariatric surgery in the US underwent the procedure between 1998 and 2006, suggesting that the impact of potential bariatric surgery in the control NHANES III group would be relatively low <sup><a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_565056026">34</a></sup>.</p><p id="P29" class="p p-last">In conclusion, we have shown that features found at baseline liver histology predict long-term overall survival in severely obese subjects undergoing bariatric surgery. Our results also suggest that a subgroup of subjects with NASH and a poor prognosis 32-gene signature is at particularly high risk of long-term mortality after bariatric surgery and may require specific management and follow-up. We believe these findings also reinforce the role of systematic perioperative liver biopsy in subjects undergoing bariatric surgery as a prognostic and diagnostic tool. Further experimental and clinical studies will be required to characterize and define these novel findings.</p></div><div id="S22" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="S22title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><div class="sup-box half_rhythm" id="d37e644"><a href="/pmc/articles/PMC4838546/bin/NIHMS731824-supplement-supplement_1.pdf">Click here to view.</a><sup>(365K, pdf)</sup></div></div></div><div id="S19" class="tsec sec"><h2 class="head no_bottom_margin" id="S19title">Acknowledgments</h2><div class="sec"><p id="__p1"><strong>Grant Support</strong></p><p id="__p2">This work was supported by grants from the FLAGS foundation, the Nuovo-Soldati Cancer Research Foundation and an advanced training grant from Geneva University Hospital to NG and by NIH/NIDDK R01 DK099558, Irma T. Hirschl Trust, and Dr. Harold and Golden Lamport Research Award to YH</p></div></div><div id="GL" class="tsec sec"><h2 class="head no_bottom_margin" id="GLtitle">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td id="G1">AIC</td><td>Akaike information criteria</td></tr><tr><td id="G2">ALT</td><td>alanine transaminase</td></tr><tr><td id="G3">BMI</td><td>body mass index</td></tr><tr><td id="G4">EBMIL</td><td>excess BMI loss</td></tr><tr><td id="G5">EGF</td><td>epidermal growth factor</td></tr><tr><td id="G6">FDR</td><td>false discovery rate</td></tr><tr><td id="G7">HBV</td><td>hepatitis B virus</td></tr><tr><td id="G8">HCV</td><td>hepatitis C virus</td></tr><tr><td id="G9">HR</td><td>hazard ratio</td></tr><tr><td id="G10">MEGENA</td><td>Multiscale Embedded Gene Co-expression Network Analysis</td></tr><tr><td id="G11">mTOR</td><td>mechanistic target of rapamycin</td></tr><tr><td id="G12">NAFLD</td><td>non-alcoholic fatty liver disease</td></tr><tr><td id="G13">NAS</td><td>NAFLD activity score</td></tr><tr><td id="G14">NASH</td><td>non-alcoholic steatohepatitis</td></tr><tr><td id="G15">NHANES III</td><td>National Health and Nutrition Examination Survey</td></tr><tr><td id="G16">OR</td><td>odds ratio</td></tr></tbody></table></div></div></div><div id="idm140598719898656" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140598719898656title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"><p id="__p3" class="p p-first"><strong>Disclosures</strong></p><p id="__p4" class="p p-last">The authors disclose no conflicts</p></p><p class="fn sec" id="FN3"><p id="__p5" class="p p-first"><strong>Transcript Profiling</strong></p><p id="__p6" class="p">Microarray data are available at National Center for Biotechnology Information Gene Expression Omnibus (<a id="__tag_565056044" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE69248" ref="/geo/query/acc.cgi?acc=GSE69248"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE69248","term_id":"69248"}}</span>GSE69248</a>).</p><p id="__p7" class="p p-last">Reviewer access link to the transcriptome profiling dataset: <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=clsncgimvbajneb&#x00026;acc=GSE69248" ref="reftype=extlink&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=clsncgimvbajneb&#x00026;acc=<a id="__tag_565056043" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE69248" ref="/geo/query/acc.cgi?acc=GSE69248"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE69248","term_id":"69248"}}</span>GSE69248</a></a></p></p><div><p id="__p8" class="p p-first"><strong>Author Contributions</strong></p>study concept and design: NG, YH, JLF, LS, FN, LRB, EG<p id="__p10" class="p">acquisition of data: NG, LS, MJ, WS, LRB, EG</p><p id="__p11" class="p">analysis and interpretation of data: NG, YH, WS, EG</p><p id="__p12" class="p">drafting of the manuscript: NG</p><p id="__p13" class="p">critical revision of the manuscript for important intellectual content: all authors</p><p id="__p14" class="p p-last">obtained funding: NG, YH, JLF, LRB, EG</p>.</div><p class="fn sec" id="FN5"><p id="__p15" class="p p-first-last"><strong>Publisher's Disclaimer: </strong>This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p></p></div></div><div id="idm140598685538912" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140598685538912title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Finkelstein EA, Trogdon JG, Cohen JW, et al.  Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates. <span><span class="ref-journal">Health Affairs. </span>2009;<span class="ref-vol">28</span>(5):w822–w31.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19635784" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Ogden CL, Carroll MD, Kit BK, et al.  Prevalence of childhood and adult obesity in the united states, 2011&#x02013;2012. <span><span class="ref-journal">JAMA. </span>2014;<span class="ref-vol">311</span>(8):806–14.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4770258/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24570244" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Ng M, Fleming T, Robinson M, et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980&#x02013;2013: a systematic analysis for the Global Burden of Disease Study 2013. <span><span class="ref-journal">The Lancet. </span><span class="ref-vol">384</span>(9945):766–81.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4624264/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24880830" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Browning JD, Szczepaniak LS, Dobbins R, et al.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. <span><span class="ref-journal">Hepatology. </span>2004;<span class="ref-vol">40</span>:1387–95.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15565570" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Loomba R, Sanyal AJ. The global NAFLD epidemic. <span><span class="ref-journal">Nat Rev Gastroenterol Hepatol. </span>2013;<span class="ref-vol">10</span>(11):686–90.</span> Epub 2013/09/18.  <span class="nowrap ref pubmed">[<a href="/pubmed/24042449" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. <span><span class="ref-journal">J Hepatol. </span>2006;<span class="ref-vol">45</span>(4):600–6.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16899321" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Puzziferri N, Roshek TB, 3rd, Mayo HG, et al.  Long-term follow-up after bariatric surgery: a systematic review. <span><span class="ref-journal">JAMA. </span>2014;<span class="ref-vol">312</span>(9):934–42.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4409000/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25182102" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Adams TD, Gress RE, Smith SC, et al.  Long-Term Mortality after Gastric Bypass Surgery. <span><span class="ref-journal">New England Journal of Medicine. </span>2007;<span class="ref-vol">357</span>(8):753–61.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17715409" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Sj&#x000f6;str&#x000f6;m L, Narbro K, Sj&#x000f6;str&#x000f6;m CD, et al.  Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects. <span><span class="ref-journal">New England Journal of Medicine. </span>2007;<span class="ref-vol">357</span>(8):741–52.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17715408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Maciejewski ML, Livingston EH, Smith VA, et al.  Survival among high-risk patients after bariatric surgery. <span><span class="ref-journal">JAMA. </span>2011;<span class="ref-vol">305</span>(23):2419–26.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21666276" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Flum DR, Belle SH, King WC, et al.  Perioperative safety in the longitudinal assessment of bariatric surgery. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">361</span>(5):445–54.</span> Epub 2009/07/31. <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2854565/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19641201" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Thomas H, Agrawal S. Systematic Review of Obesity Surgery Mortality Risk Score&#x02014;Preoperative Risk Stratification in Bariatric Surgery. <span><span class="ref-journal">Obesity Surgery. </span>2012;<span class="ref-vol">22</span>(7):1135–40.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22535443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Livingston EH, Huerta S, Arthur D, et al.  Male Gender is a Predictor of Morbidity and Age a Predictor of Mortality for Patients Undergoing Gastric Bypass Surgery. <span><span class="ref-journal">Annals of Surgery. </span>2002;<span class="ref-vol">236</span>(5):576–82.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1422615/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12409663" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Arterburn D, Livingston EH, Schifftner T, et al.  Predictors of long-term mortality after bariatric surgery performed in veterans affairs medical centers. <span><span class="ref-journal">Archives of Surgery. </span>2009;<span class="ref-vol">144</span>(10):914–20.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19841358" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Chassot G, Huber O, Koutny-Fong P, et al.  Surgical treatment of obesity in 2006. <span><span class="ref-journal">Rev Med Suisse. </span>2006;<span class="ref-vol">2</span>(70):1568–71.</span> Epub 2006/07/15. Chirurgie de l&#x02019;obesite en 2006.  <span class="nowrap ref pubmed">[<a href="/pubmed/16838722" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Kleiner DE, Brunt EM, Van Natta M, et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease. <span><span class="ref-journal">Hepatology. </span>2005;<span class="ref-vol">41</span>(6):1313–21.</span> Epub 2005/05/26.  <span class="nowrap ref pubmed">[<a href="/pubmed/15915461" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Brunt EM, Kleiner DE, Wilson LA, et al.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. <span><span class="ref-journal">Hepatology. </span>2011;<span class="ref-vol">53</span>(3):810–20.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3079483/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21319198" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Centers for Disease Control Prevention (CDC), National Center for Health Statistics (NCHS)  U.S. Department of Health and Human Services, CDC, editor.  <span class="ref-journal">National Health and Nutrition Examination Survey III, 1988&#x02013;1994.</span> Hyattsville, MD: 1998. </span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">King LY, Canasto-Chibuque C, Johnson KB, et al.  A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration. <span><span class="ref-journal">Gut. </span>2014</span> Epub 2014/08/22. <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4336233/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25143343" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Hoshida Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. <span><span class="ref-journal">PloS one. </span>2010;<span class="ref-vol">5</span>(11):e15543.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2990751/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21124904" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Song W-M, Di Matteo T, Aste T. Building complex networks with Platonic solids. <span><span class="ref-journal">Physical Review E. </span>2012;<span class="ref-vol">85</span>(4):046115.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22680546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Song W-M, Di Matteo T, Aste T. Nested hierarchies in planar graphs. <span><span class="ref-journal">Discrete Applied Mathematics. </span>2011;<span class="ref-vol">159</span>(17):2135–46.</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Moylan CA, Pang H, Dellinger A, et al.  Hepatic gene expression profiles differentiate pre-symptomatic patients with mild versus severe nonalcoholic fatty liver disease (Severe NAFLD Gene Signature) <span><span class="ref-journal">Hepatology. </span>2013</span> Epub 2013/08/06. <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3982589/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23913408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Fuchs BC, Hoshida Y, Fujii T, et al.  Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. <span><span class="ref-journal">Hepatology. </span>2014;<span class="ref-vol">59</span>(4):1577–90.</span> Epub 2014/03/29. <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4086837/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24677197" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Drews F, Knobel S, Moser M, et al.  Disruption of the latent transforming growth factor-beta binding protein-1 gene causes alteration in facial structure and influences TGF-beta bioavailability. <span><span class="ref-journal">Biochim Biophys Acta. </span>2008;<span class="ref-vol">1783</span>(1):34–48.</span> Epub 2007/10/24.  <span class="nowrap ref pubmed">[<a href="/pubmed/17950478" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Zhang D, Goossens N, Guo J, et al.  A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection. <span><span class="ref-journal">Gut. </span>2015</span> Accepted. <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4848165/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26045137" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Mathurin P, Hollebecque A, Arnalsteen L, et al.  Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease. <span><span class="ref-journal">Gastroenterology. </span>2009;<span class="ref-vol">137</span>(2):532–40.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19409898" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Lassailly G, Caiazzo R, Buob D, et al.  Bariatric Surgery Reduces Features of Non-alcoholic Steatohepatitis in Morbidly Obese Patients. <span><span class="ref-journal">Gastroenterology. </span>2015</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25917783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Angulo P, Kleiner DE, Dam-Larsen S, et al.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">149</span>(2):389–97. e10.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4516664/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25935633" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Ekstedt M, Hagstrom H, Nasr P, et al.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. <span><span class="ref-journal">Hepatology. </span>2014</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25125077" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Henao-Mejia J, Elinav E, Jin C, et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. <span><span class="ref-journal">Nature. </span>2012;<span class="ref-vol">482</span>(7384):179–85.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3276682/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22297845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Lazo M, Hernaez R, Bonekamp S, et al.  Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. <span><span class="ref-journal">BMJ. </span>2011:343.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3220620/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22102439" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. <span><span class="ref-journal">J Hepatol. </span>2008;<span class="ref-vol">49</span>(4):608–12.</span> Epub 2008/08/07.  <span class="nowrap ref pubmed">[<a href="/pubmed/18682312" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Nguyen NT, Masoomi H, Magno CP, et al.  Trends in Use of Bariatric Surgery, 2003&#x02013;2008. <span><span class="ref-journal">Journal of the American College of Surgeons. </span>2011;<span class="ref-vol">213</span>(2):261–6.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21624841" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4838546&amp;issue-id=268359&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4838546/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4838546/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4838546/pdf/nihms731824.pdf">PDF (747K)</a></li> | <li><a href="#" data-citationid="PMC4838546" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4838546%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4838546%2F&amp;text=Non-alcoholic%20Steatohepatitis%20is%20Associated%20with%20Increased%20Mortality%20in%20Obese%20Patients%20Undergoing%20Bariatric%20Surgery"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4838546%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="26492845" data-aiid="4838546" data-aid="4838546" data-iid="268359" data-domainid="319" data-domain="nihpa" data-accid="PMC4838546" data-md5="f7b5b2276bc51af997c985aaa204e71c"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-07-16T19:05:50-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc202&amp;ncbi_phid=F4FC664DB4D23EE100000000006B0059&amp;ncbi_session=F4FC664DB4D24CD1_0107SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4838546%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4838546/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC664DB4D24CD1_0107SID /projects/PMC/PMCViewer@4.46 ptpmc202 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>